On July 28, 2020, we entered into a Loan and Security Agreement (the Loan and Security Agreement) with our subsidiary, Corbus Pharmaceuticals, Inc., as borrower, us, as guarantor, and each lender party thereto (the Lenders), K2 HealthVentures LLC ("K2HV"), an unrelated third party, as administrative agent for the Lenders, and Ankura Trust Company, LLC, an unrelated third party, as collateral agent for the Lenders, pursuant to which K2HV provided us with a term loan of $20,000,000 upon signing
Our multimodal treatment with antioxidants was therefore suspended
BPC-157 ,
Some research shows that the supplement may help to suppress HIV-1 reproduction
We'll explore what Labial Melanotic Macule is, its causes, and most importantly, share some practical tips for managing and embracing your skin's distinct features